Mendelian Randomization Combined with Bioinformatics Revealed Specific Allergy-Mediated Protective Mechanisms Against Renal Cell Carcinoma
Open Access
- 1 October 2025
- journal article
- research article
- Published by Springer Nature in Phenomics
- Vol. 5 (5) , 577-589
Abstract
There is evidence that allergic diseases are associated with carcinogenesis. According to translational and epidemiological data, it appears that different cancer types yield different associations. We investigated the relationship between allergic diseases and 28 cancers by Mendelian randomization. Quantitative trait locus analysis was utilized to determine genes expressed in kidney tissue that were affected by allergy-related loci. We further explored the underlying molecular mechanism between allergic diseases and renal cell carcinoma (RCC) with bioinformatics. Of the 28 cancers, evidence suggested that allergies specifically suppressed kidney cancer. Seventy single nucleotide polymorphisms associated with allergic diseases affected the expression of 134 genes in kidney tissue. These 134 genes were enriched in immune-related pathways represented by the major histocompatibility complex class II antigen presentation pathway. Among them, seven core genes were significantly positively correlated with T helper 2 cells. Allergic diseases specifically suppressed RCC through multiple immune pathways. Among them, the major histocompatibility complex class II antigen presentation pathway and T helper 2 cells were the most critical. Our study sheds light on the underlying mechanisms of allergic diseases and RCC and provides therapeutic targets for RCC.Keywords
This publication has 44 references indexed in Scilit:
- Anti-tumor activity of trimethoprim-sulfamethoxazole against melanoma skin cancer through triggering allergic reaction and promoting immunityInternational Immunopharmacology, 2023
- Glatiramer acetate enhances tumor retention and innate activation of immunostimulantsInternational Journal of Pharmaceutics, 2021
- IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural statesEBioMedicine, 2019
- Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophagesBiomaterials, 2018
- Opposing roles of eosinophils in cancerCancer Immunology, Immunotherapy, 2018
- SnapShot: TCGA-Analyzed TumorsCell, 2018
- An Integrated Metabolic Atlas of Clear Cell Renal Cell CarcinomaCancer Cell, 2016
- Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort studyCancer Causes & Control, 2010
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- Ultrastructural evidence of the mechanisms responsible for interleukin‐4‐activated rejection of a spontaneous murine adenocarcinomaInternational Journal of Cancer, 1993